FFOX Among Its Peers
End-of-day Nov 20, 2026 · 1 ETFs by 1M
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −4.3% | −9.9% | −11.3% | −17.5% | −9.4% | −7.0% | — | — | — | −0.4% |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$21 of every $1,000 in FFOX is Q2
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | —First American Government Obligations Fund 12/01/2031 | — | 5.55% | $554.78 | 11.8M | $11.8M |
| 2 | QTWOQ2 | Technology | 2.06% | $205.95 | 65K | $4.4M |
| 3 | LGNDLigand Pharmaceuticals | Healthcare | 2.06% | $205.63 | 15K | $4.4M |
| 4 | LFUSLittelfuse | Technology | 2.01% | $201.03 | 11K | $4.3M |
| 5 | WTFCWintrust Financial | Financial Services | 1.90% | $189.87 | 27K | $4.0M |
| 6 | GMEDGlobus Medical | Healthcare | 1.86% | $185.56 | 58K | $3.9M |
| 7 | HRIHerc | Industrials | 1.85% | $184.53 | 26K | $3.9M |
| 8 | IDCCInterDigital | Technology | 1.82% | $182.00 | 14K | $3.9M |
| 9 | HQYHealthEquity | Healthcare | 1.80% | $179.97 | 39K | $3.8M |
| 10 | MRCYMercury Systems | Industrials | 1.77% | $177.07 | 49K | $3.8M |
| 11 | HALOHalozyme Therapeutics | Healthcare | 1.77% | $176.96 | 40K | $3.8M |
| 12 | WTSWatts Water Technologies | Industrials | 1.74% | $173.95 | 10K | $3.7M |
| 13 | RDNTRadNet | Healthcare | 1.73% | $173.47 | 53K | $3.7M |
| 14 | SXTSensient Technologies | Basic Materials | 1.72% | $171.81 | 31K | $3.7M |
| 15 | VIKViking | Consumer Cyclical | 1.72% | $171.76 | 38K | $3.7M |
FFOX has no close peers in our data yet: […]
No peers with a full year of prices to rank against yet.
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | QTWO | Q2 | 2.06% |
| 2 | LGND | Ligand Pharmaceuticals | 2.06% |
| 3 | LFUS | Littelfuse | 2.01% |
| 4 | WTFC | Wintrust Financial | 1.90% |
| 5 | GMED | Globus Medical | 1.86% |
| 6 | HRI | Herc | 1.85% |
| 7 | IDCC | InterDigital | 1.82% |
| 8 | HQY | HealthEquity | 1.80% |
| 9 | MRCY | Mercury Systems | 1.77% |
| 10 | HALO | Halozyme Therapeutics | 1.77% |
| Fund | Sharpe | Sortino | Volatility | Max DD | Beta | Fee / $10k |
|---|---|---|---|---|---|---|
| FFOX | −0.50 | −0.69 | 20.0% | −20.9% | 1.17 | $100 |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 31, 2025 | Jan 2, 2026 | $0.49 |